Is Complete Revascularisation Mandated for all Patients with Multivessel Coronary Artery Disease?

• Published in: Interventional cardiology (London) 2018, Vol.13 (1), p.45-50
• Main Authors: De Innocentiis, Carlo, Zimarino, Marco, De Caterina, Raffaele
• Format: Article
• Language: English
• Subjects: Coronary
• ISSN: 1756-1477; 1756-1477
• DOI: 10.15420/icr.2017:23:1

In multivessel coronary artery disease (MVCAD), myocardial revascularisation can be achieved by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), with complete revascularisation on all diseased coronary segments or with incomplete revascularisation on selectively targeted lesions. Complete revascularisation confers a long-term prognostic benefit, but is associated with a higher rate of periprocedural events compared with incomplete revascularisation. In most patients with MVCAD, the main advantage of CABG over PCI is conferred by the achievement of more extensive revascularisation. According to current international guidelines, PCI is generally preferred in single-vessel disease, low-risk MVCAD or isolated left main disease; whereas CABG is usually recommended in patients with complex two-vessel disease, most patients with three-vessel disease and/or non-isolated left main disease. In patients with MVCAD, the choice on revascularisation modality should depend on a multifactorial evaluation, taking into account not only coronary anatomy, the ischaemic burden, myocardial function, age and the presence of comorbidities, but also the adequacy of myocardial revascularisation.